EUVIMEDEUVIMED entdecken
Klinische StudieEvaluationsstudieMultizentrische StudieOpen Access

Evaluation of AI‐derived LAD artery dose metrics for survival stratification in stage III NSCLC: A secondary analysis of RTOG 0617 trial

Libing Zhu, Yi Rong, Randa Tao, Yun Bai, Nathan Y Yu, Quan Chen

Medical Physics · 2026-08 · 53 (8)

DOI: 10.1002/mp.70621 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Medical Physics, online erschienen am 03.08.2026. Verfasst von Libing Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona, USA. Hauptthemen laut MEDLINE: Artificial Intelligence, Carcinoma, Non-Small-Cell Lung, Coronary Vessels, Deep Learning. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Mayo Clinic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

While the radiation dose to left anterior descending (LAD) artery is associated with overall survival (OS) in NSCLC patients, manual segmentation is labor‐intensive. Several auto‐segmentation models were developed on average 4DCT with promising geometric agreement, yet their feasibility in clinical outcome analysis on lung CT remains unclear.

Purpose

This study evaluates whether automated LAD segmentation can reproduce, at the group level, the established dose‐survival association in a multi‐institutional clinical trial dataset.

Methods

Three deep learning‐based auto‐segmentation (DLAS) models for automatic segmentation of the LAD coronary artery were applied to 460 patients from the NRG Oncology/RTOG 0617 dataset. Kaplan–Meier curves and Cox proportional hazard ratio (HR) were calculated using each model's segmentation. The LAD V15 Gy was used to stratify patients into high‐and low‐risk groups, and the cut‐off values were determined by minimizing mean absolute error (MAE) between DLAS‐derived and manual OS curves.

Results

All three models demonstrated significantly different OS curves between the high risk and low risk groups ( p < 0.05). The HR was 1.40 (95% CI: 1.02–1.93; p = 0.0381; MAE = 7.1%), 1.32 (95% CI: 1.03–1.68; p = 0.0258; MAE = 9.6%), and 1.37 (95% CI: 1.03–1.84; p = 0.0331; MAE = 7.9%) for the three models using a common V15 Gy ≥ 10% cut‐off. After optimizing the cut‐off, one model aligned well with what was derived from manual segmentation (MAE = 4.3%).

Conclusion

Among the evaluated models, one DL model showed the strongest performance of survival groups separation and achieved group‐level overall survival stratification comparable to that previously reported using manual contours in the multi‐institutional cohort. Further validation with paired manual contours and pre‐specified cutoffs is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceCarcinoma, Non-Small-Cell LungCoronary VesselsDeep LearningImage Processing, Computer-AssistedLung NeoplasmsRadiation DosageHumansNeoplasm StagingRadiotherapy DosageSurvival Analysis

Stichwörter der Autor:innen

LAD coronary arteryauto segmentationdeep learningpatient outcome

Autor:innen und Institutionen

  • Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona, USA.

Förderung

  • Mayo Clinic

Zitieren

APA

Zhu, L., Rong, Y., Tao, R., Bai, Y., Yu, N. Y., & Chen, Q. (2026). Evaluation of AI‐derived LAD artery dose metrics for survival stratification in stage III NSCLC: A secondary analysis of RTOG 0617 trial. Medical Physics, 53(8). https://doi.org/10.1002/mp.70621

Vancouver

Zhu L, Rong Y, Tao R, Bai Y, Yu NY, Chen Q. Evaluation of AI‐derived LAD artery dose metrics for survival stratification in stage III NSCLC: A secondary analysis of RTOG 0617 trial. Medical Physics. 2026;53(8). doi:10.1002/mp.70621

BibTeX
@article{Zhu2026,
  author = {Zhu, Libing and Rong, Yi and Tao, Randa and Bai, Yun and Yu, Nathan Y and Chen, Quan},
  title = {Evaluation of AI‐derived LAD artery dose metrics for survival stratification in stage III NSCLC: A secondary analysis of RTOG 0617 trial},
  journal = {Medical Physics},
  year = {2026},
  volume = {53},
  number = {8},
  doi = {10.1002/mp.70621}
}
Kostenlos starten →